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The ‘verification phase’ has emerged as a supplementary procedure to traditional maximal
oxygen uptake (VO2max) criteria to confirm that the highest possible VO2 has been attained
during a cardiopulmonary exercise test (CPET).
Objective
To compare the highest VO2 responses observed in different verification phase procedures
with their preceding CPET for confirmation that VO2max was likely attained.
Methods
MEDLINE (accessed through PubMed), Web of Science, SPORTDiscus, and Cochrane
(accessed through Wiley) were searched for relevant studies that involved apparently
healthy adults, VO2max determination by indirect calorimetry, and a CPET on a cycle ergom-
eter or treadmill that incorporated an appended verification phase. RevMan 5.3 software
was used to analyze the pooled effect of the CPET and verification phase on the highest
mean VO2. Meta-analysis effect size calculations incorporated random-effects assumptions
due to the diversity of experimental protocols employed. I2 was calculated to determine the
heterogeneity of VO2 responses, and a funnel plot was used to check the risk of bias, within
the mean VO2 responses from the primary studies. Subgroup analyses were used to test
the moderator effects of sex, cardiorespiratory fitness, exercise modality, CPET protocol,
and verification phase protocol.
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Received: August 13, 2020
Accepted: January 30, 2021
Published: February 17, 2021
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0247057
Copyright: © 2021 Costa et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting information
files.
Results
Eighty studies were included in the systematic review (total sample of 1,680 participants;
473 women; age 19–68 yr.; VO2max 3.3 ± 1.4 L/min or 46.9 ± 12.1 mL�kg-1�min-1). The high-
est mean VO2 values attained in the CPET and verification phase were similar in the 54
studies that were meta-analyzed (mean difference = 0.03 [95% CI = -0.01 to 0.06] L/min,
P = 0.15). Furthermore, the difference between the CPET and verification phase was not
affected by any of the potential moderators such as verification phase intensity (P = 0.11),
type of recovery utilized (P = 0.36), VO2max verification criterion adoption (P = 0.29), same
or alternate day verification procedure (P = 0.21), verification-phase duration (P = 0.35), or
even according to sex, cardiorespiratory fitness level, exercise modality, and CPET protocol
(P = 0.18 to P = 0.71). The funnel plot indicated that there was no significant publication
bias.
Conclusions
The verification phase seems a robust procedure to confirm that the highest possible VO2
has been attained during a ramp or continuous step-incremented CPET. However, given
the high concordance between the highest mean VO2 achieved in the CPET and verification





Maximal oxygen uptake (VO2max) represents the upper physiological limit of the utilization of
oxygen for producing energy during strenuous exercise performed until volitional exhaustion
[1, 2]. The VO2max is widely regarded as the gold standard measure of cardiorespiratory fitness
and is typically determined using a cardiopulmonary exercise test (CPET) in clinical, applied
physiology, and sport and exercise science settings [1, 3–6]. The VO2max is often used to diag-
nose cardiovascular disease [7], predict all-cause mortality [8–10], develop exercise prescrip-
tions [3, 11, 12], and evaluate the efficacy of exercise programmes [13–15]. Consequently, the
validity of VO2max values obtained during CPETs has widespread importance in clinical, sport-
ing, and research-related contexts.
The use of indirect calorimetry for the determination of VO2max during exercise testing to
volitional exhaustion on a treadmill or cycle ergometer has become common during the past
few decades [16–18]. This has largely been attributed to the development of fast-responding
metabolic gas analyzers allowing the time-efficient acquisition of real-time, breath-by-breath,
respiratory gas exchange and flow rate data during CPET [see 19 for a review]. These techno-
logical advances have contributed to a transition from the Douglas bag method and time-con-
suming discontinuous step-incremented protocols to more time-efficient continuous ramp or
pseudo-ramp protocols for determining VO2max [20–25]. Despite the considerable progress in
the efficiency by which CPET can be conducted and evaluated, there is still much to be learned
about the determination of VO2max [2, 24–30]. One particularly problematic aspect has been
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the challenge in identifying a lack of VO2max attainment due to inappropriate test protocols,
premature fatigue, or poor participant motivation and lack of effort [31].
The concept of a VO2max originated almost 100 years ago with the seminal works of Hill and
colleagues [32, 33]. They proposed the existence of an individual upper limit or ‘ceiling’ of VO2
during maximal exercise, beyond which no further increase in VO2 occurs despite increasing
work rate (WR) and higher metabolic demand. The primary criterion for confirming that a
VO2max has been elicited has historically been based on the occurrence of a VO2 plateau, com-
monly defined as a small or no increase in VO2 despite a continued increase in WR [34]. The
landmark study of Taylor et al. [34] was the first to use a formal VO2 plateau criterion, which
was defined as an increase in VO2 of less than 0.150 L/min (or� 2.1 mL�kg
-1�min-1, consider-
ing an average body mass of 72 kg from 115 male participants) in response to a specific discon-
tinuous step-incremented protocol performed over 3–5 laboratory visits. Subsequent studies
have often used the Taylor et al. [34] criterion or alternative thresholds to confirm the attain-
ment of a VO2 plateau [see 29 for a review]. Since the widespread adoption of continuous
short-duration and ramp-based CPET protocols, several studies have reported low incidences
of the VO2 plateau [35–39]. The variability in VO2 plateau incidence has been attributed to dif-
ferences in the criteria used for detecting the VO2 plateau [29, 40], VO2 sampling intervals [36,
41, 42], exercise modality [43], the warm-up prior to the CPET [44], type of CPET protocol
[45–48], and various participant characteristics [49–51].
In the absence of a VO2 plateau, secondary VO2max criteria based upon achievement of
threshold values for the respiratory exchange ratio (RER), percentage of age-predicted maxi-
mal heart rate, post-exercise blood lactate concentration, and ratings of perceived exertion
(RPE) have become commonly used to evaluate whether a true VO2max has been attained [29,
40]. However, this approach has been widely criticized by numerous investigators due to the
individual variability in maximal physiological responses for these variables and lack of speci-
ficity in identifying individuals who did not continue the CPET to their limit of exercise toler-
ance. Research has shown that some individuals can satisfy some of the secondary criteria
thresholds long before the highest VO2 value observed in the CPET has been attained [2, 29,
37, 39]. The maximal RER criterion, for example, can be satisfied at VO2 values 27–39% lower
than the highest VO2 value achieved in the CPET [37, 39]. Like the VO2 plateau, secondary
VO2max criteria are often dependent on exercise modality, test protocol, and participant char-
acteristics [29].
A review by Midgley et al. [29] suggested a new set of standardized VO2max criteria should
be developed that are independent of exercise modality, test protocol, and participant charac-
teristics, so they can be universally applied. In 2009, Midgley and Carroll [28] provided an
early narrative review of an evolving test procedure that showed promise for developing more
standardized VO2max criteria, the so-called ‘verification phase’. The verification phase consists
of an appended square wave bout of severe-intensity exercise (e.g. above critical power), or
similar multistage exercise bout, performed until the limit of exercise tolerance [28]. It is com-
monly applied after a short recovery period from a CPET, however, longer recovery periods of
up to 24–48 hours also have been used [52]. The verification phase is based on the premise that
when the highest VO2 values in the CPET are consistent with the verification phase (typically
within 2–3% in accordance with the test-retest reliability of VO2max), this provides substantial
empirical support that the highest possible VO2 has been elicited. Poole and Jones [2] recently
stated that to confirm the attainment of VO2max a verification phase should be performed at a
higher WR than the last load attained in the CPET (i.e. > WRpeak) in all future studies. Con-
versely, Iannetta et al. [25] recommended WRs within the upper limit of the severe exercise
intensity domain to allow the verification phase to be maintained long enough for VO2max
attainment. According to their recent findings, verification phases performed at 110% of the
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WRpeak attained during CPETs with increment rates of 25 and 30 W/min resulted in exercise
durations that were too short to allow VO2 to reach the highest VO2 recorded at the end of the
preceding ramp CPETs [25]. Along with exercise intensity and duration, it is also unclear
whether other factors affect the utility of the verification phase such as exercise modality, dif-
ferences in the type and duration of the recovery period between the verification phase and
CPET, whether a verification criterion threshold is adopted, and participant characteristics
such as sex and cardiorespiratory fitness levels.
Given the considerable uncertainty regarding the application of the verification phase, it is
feasible to think that a systematic review and meta-analysis is needed to comprehensively sum-
marize the evidence for improving our understanding of the strengths and weaknesses of the
substantial number of different verification procedures that have been utilized and its impact
on the attainment of VO2max. Thus, the aim of the present study was to systematically review
and provide a meta-analysis on the application of the verification phase for confirming
whether the highest possible VO2 has been attained during ramp or step-incremented CPETs
in apparently healthy adults.
Methods
Protocol and registration
The systematic review was performed in accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A completed PRISMA checklist
is shown in S1 Checklist. The protocol for this study was recorded at http://www.crd.york.ac.
uk/PROSPERO (CRD42019123540). The main questions addressed by the present study were:
To what extent does the highest VO2 attained in the CPET differ from that attained in the veri-
fication phase? Secondly, are the highest VO2 values in the CPET and verification phase
affected by the verification-phase characteristics (e.g. intensity, adoption of a criterion thresh-
old, and aspects of the recovery period between the CPET and the verification phase), or even
with respect to particular subgroups (e.g. sex, cardiorespiratory fitness levels, exercise test
modality, and CPET protocol design) in apparently healthy adults?
Search strategy
MEDLINE (accessed through PubMed), Web of Science, SPORTDiscus, and Cochrane
(accessed through Wiley) were searched for peer-reviewed literature using a combination of
medical subject heading (MeSH) descriptors, with a time frame that spanned the inception of
each database until the search date (September 30th, 2020). The search strategy was developed
based on the PICO method [i.e. Participants: apparently healthy humans; Interventions: any
intervention involving exercise; Comparisons: incremental CPET and an appended square-
wave or multistage verification phase; and Outcome: VO2max confirmation]. The electronic
search strategies for all databases are provided in S1 Text.
The terms were adapted for use with other bibliographic databases. Reference lists and cita-
tions of eligible articles were also hand searched for additional relevant studies. The search was
performed in a standardized manner by two independent researchers (VABC and TP). Only
English language studies were eligible for inclusion and only if they satisfied three a priori cri-
teria: (1) involved apparently healthy participants who were� 18 years of age; (2) determined
VO2max using expired gas analysis indirect calorimetry; and (3) the CPET was carried out
using bipedal cycle ergometer or bipedal treadmill running or walking. Studies were excluded
if they involved: (1) participants who had taken dietary supplements or drugs that could affect
body mass, metabolic profile, or exercise performance; or (2) the use of non-maximal test
protocols.
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Study selection
Potential studies were screened for inclusion using three methods: (1) title only; (2) title and
abstract; and (3) full-text review. Two investigators independently searched and selected arti-
cles, and coauthors subsequently confirmed articles to be included in the analysis. Disagree-
ments were resolved by consensus. Agreement between investigators with respect to inclusion
and/or exclusion of potential trials was ratified in 252 randomly selected abstracts by means of
Cohen’s kappa (κ = 0.811, P< 0.05). Fig 1 summarizes the screening and selection process.
Fig 1. Flowchart of the systematic review and meta-analysis according to the PRISMA guidelines. VO2max: maximal oxygen uptake.
https://doi.org/10.1371/journal.pone.0247057.g001
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Data extraction and management
Two independent reviewers extracted data using a standardized form. The following data were
summarized: (1) characteristics of study participants (total sample number, sex, age, body
mass index [BMI], and cardiorespiratory fitness); (2) type of intervention (CPET and verifica-
tion-phase duration, exercise modality, and exercise test protocol used); and (3) outcome mea-
sures (mean ± standard deviation [SD] for group VO2max and protocol duration during the
CPET and verification phase). Disagreements were resolved by consensus. When the relevant
quantitative data were not reported, authors of the original studies were contacted to request
the data.
Quality assessment
The risk of bias for all eligible studies was not assessed because it does not apply to the charac-
teristics of the present review. For example, randomization sequence generation and treatment
allocation concealment were not applied, since there were no comparison groups and each
individual acted as their own control. It is also noteworthy to mention the absence of blinding
in both participants undergoing testing and evaluators who applied the CPET and verification
phases, because procedurally all exercise protocols were performed in a fixed order (i.e. CPET
followed by the verification phase). Given that VO2max is the evaluation of an objective numer-
ical variable, the blinding of the evaluator does not generate a different interpretation of the
VO2max values obtained in a CPET and verification phase. Finally, the assessment of incom-
plete outcome data (sample loss) and selective reporting of outcomes also does not apply,
because it is a cross-sectional study with a single outcome of interest.
Statistical analysis
All meta-analyses were performed using Review Manager (RevMan) software version 5.3
(Copenhagen, The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). Data are
presented as the mean ± SD unless otherwise stated. The outcome was the mean difference
(95% confidence interval [CI]) between the CPET and verification phase for the highest abso-
lute VO2 (L/min). Given that absolute VO2 are continuous data, the weighted mean difference
(WMD) method was used for combining study effect size estimates. With the WMD method,
the pooled effect estimate represents a weighted mean of all included study group compari-
sons. The weighting assigned to each individual study group (i.e. the comparison of the CPET
and verification phase results) in the analysis is inversely proportional to the variance of the
absolute VO2 (L/min). This method typically assigns more weight in the meta-analysis to stud-
ies with the highest precision (inverse variance) /larger sample sizes. The WMDs were calcu-
lated using random-effects models given the study group differences in CPET modalities and
protocols, types of recovery, and verification phase protocols.
Heterogeneity of net study group changes in VO2max (L/min) was examined using the Q
statistic. Cochran’s Q statistic is computed by summing the squared deviations of each trial’s
estimate from the overall meta-analytic estimate and weighting each trial’s contribution in the
same manner as in the meta-analysis. P-values were obtained by comparing the statistic with a
χ2 distribution with k-1 degrees of freedom (where k is the number of trials). A P-value
of< 0.10 was adopted since the Q statistic tends to suffer from low differential power. The for-
mal Q statistic was used in conjunction with the methods for assessing heterogeneity. The I2
statistic measures the extent of inconsistency among the results of the primary study groups,
interpreted approximately as the proportion of total variation in point estimates that is due to
heterogeneity rather than sampling error. Effect sizes with a corresponding I2 value of� 50%
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were considered to have low heterogeneity. The publication bias of the articles was assessed
using a funnel plot.
Subgroup analyses were defined a priori to investigate the magnitude of differences between
CPETs and verification phases due to variations in sex, cardiorespiratory fitness level, exercise
modality, CPET protocol design, or how the verification phase was performed. Forest plots
were constructed to display values at the 95% confidence level. Effect sizes were calculated by
subtracting the highest mean values for VO2 (L/min) observed in the CPET from the verifica-
tion phase values, on the basis of grouping studies with selected verification-phase characteris-
tics for intensity (i.e. sub vs. supra WRpeak) and type of recovery between the CPET and
verification phase (i.e. active vs. passive). The studies were also classified according to whether
a criterion threshold for VO2max was used for the verification phase (i.e. yes vs. no), whether
the verification phase was performed in the same testing session as the CPET or on a different
day, and the duration of the verification phase (i.e.� 80 s, 81–120 s, and> 120 s). Stratified
analyses were also conducted according to particular subgroups such as sex (i.e. male and
female), cardiorespiratory fitness level using the cut-off points proposed by Astorino et al. [53]
(i.e. low:< 40 mL�kg-1�min-1; moderate: 40–50 mL�kg-1�min-1; high: > 50 mL�kg-1�min-1),
exercise test modality (i.e. cycling and running), and CPET protocol design (i.e. discontinuous
step-incremented, continuous step-incremented, and ramp protocols).
Results
The literature search identified 371 potential articles, with 334 obtained from electronic data-
base searches and 37 from the wider inspection of reference lists and electronic citations of
these articles. Eighty studies published between 1980 and 2020 met the eligibility criteria and
were included in the systematic review (see Fig 1).
Participants
The total number of participants recruited across all included studies was 1,680 (1,077 men,
473 women, and the sex of 130 participants was not specified). Included studies had a median
(interquartile range [IQR]) sample size of 13 [10] participants. Participants were aged between
19 and 68 yr, all apparently healthy, and with a physical activity status ranging from sedentary
to highly-trained endurance athletes. Thirty-six studies included only men, two included only
women, 41 included both men and women, and one study did not specify the sex of the partic-
ipants (see Table 1). On average, participants had a BMI within the normal range (mean ± SD
[range]: 24.4 ± 2.5 [19.4–32.0] kg/m2) and a moderate level of cardiorespiratory fitness
(VO2max mean ± SD [range]: 46.9 ± 12.1 [23.9–68.6] mL�kg-1�min-1).
Characteristics of studies regarding the CPET and verification phase
protocols to evaluate VO2max
Table 2 summarizes the characteristics of the CPET and verification phase protocols of the 80
studies included in this systematic review. Forty-three studies (54%) performed the CPET on a
cycle ergometer, 35 (44%) on a treadmill, and two studies (3%) used both modalities. Seventy-
three studies (91%) used continuous step-incremented or ramp/pseudo-ramp CPET protocols.
Three (4%) used only discontinuous step-incremented protocols. Two studies (3%) used both
discontinuous and continuous step-incremented protocols and another two studies (3%)
applied self-paced protocols. Thirty-three (41%) of the 80 studies included in the review used
one or more VO2 plateau or secondary VO2max criteria to confirm the attainment of VO2max.
Thirty studies used the VO2 plateau, 21 used the heart rate plateau or a criterion based on age-
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Table 1. Sample characteristics for studies that incorporated a cardiopulmonary exercise test (CPET) (k = 80).
Study mean values
Population Sex N Age BMI VO2max
M/F Years kg/m2 mL�kg-1�min-1
Alexander and Mier [54] Soccer players M/F 5/6 21.3 22.7 57.7
Arad et al. [55] Sedentary M 19 33.4 25.8 30.0
F 16 26.8 26.6 27.1
Astorino and DeRevere [56] Recreationally trained M/F 19/11 26 NS 47.2
M/F 41/38 23.3 NS 40.5
Astorino and White [57] Physically active M 13 23.5 24.3 43.8
F 17 22.9 22.0 40.7
Astorino et al. [53] Low CRF M/F 5/5 25.7 22.7 36.2
Moderate CRF M/F 5/5 26.3 24.1 46.4
High CRF M/F 9/1 26 23.7 57.9
Astorino et al. [58] Active adults (HIIT-Baseline) M/F 3/11 27 22 38.0
Active adults (HIIT—Week 3) 40.4
Active adults (Control—Baseline) M/F 8/6 23 24 40.2
Active adults (Control—Week 3) 40.5
Astorino et al. [59] Active adults M/F 14 27 22.5 38.0
Astorino et al. [60] Sedentary M/F 6/9 22.4 24.5 32.7
Sedentary M/F 1/8 21.8 22.9 42.1
Beltrami et al. [61] Runners or cross-country skiers M/F 23/3 29 23.5 61.3
Beltz et al. [62] Recreationally trained M 16 23.6 26.6 47.4
Bisi et al. [63] Healthy adults M 11 23.5 22.6 35.0
Chidnok et al. [64] Active adults M 7 20 24.8 57.7
Clark et al. [65] Adults of various fitness levels M/F 3/12 22 22.0 NS
Colakoglu et al. [66] Athletes M 9 24.2 23.0 59.7
Colakoglu et al. [67] Well-trained athletes M 9 23.6 23.1 60.2
Colakoglu et al. [68] Athletes M 9 23.6 23.1 60.2
Dalleck et al. [69] Healthy adults M/F 9/9 59.7 27.8 27.7
Day et al. [35] Healthy adults M 38 19–61 NS NS
Del Giudice et al. [70] Healthy adults M 14 21.5 22.8 60.2
Dexheimer et al. [71] Active adults M 12 29 31.4 50.6
F 5 25.6 24.4 43.7
Dicks et al. [72] Firefighters M 30 34.5 28.7 41.0
Dogra et al. [73] Older adults (trained) F 7 62.7 23.4 37.8
Older adults (untrained) F 10 68.8 26.1 24.1
Ducrocq et al. [74] Recreationally trained M/F 9/4 21.2 22.5 56.0
Elliott et al. [75] Cyclists M 8 40.5 25.2 53.7
Faulkner et al. [76] Recreationally trained M 13 25.5 24.5 63.9
Foster et al. [77] Physically active non-athletes (cycling) M 16 31.5 24.0 51.7
F 4 28 21.6
Competitive runners (treadmill running) M 12 21.6 22.9 56.3
F 8 21 20.5
Freeberg et al. [78] Healthy adults M/F 17/13 21.7 23.7 49.9
Goodall et al. [79] Cyclists M 9 28.1 23.1 61.1
Hanson et al. [80] Recreationally trained M/F 8/5 24 24.7 56.2
Hawkins et al. [81] Distance runners M/F 36/16 NS NS 63.3
Hogg et al. [82] Highly trained M 14 28 23.2 68.6
(Continued)
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Table 1. (Continued)
Study mean values
Population Sex N Age BMI VO2max
M/F Years kg/m2 mL�kg-1�min-1
Iannetta et al. [25] Recreationally trained M/F 6/5 28 21.8 52.6
James et al. [83] Squash players M/F 6/2 20.3 22.1 48.8
Jamnick et al. [84] Trained cyclists M 17 36.2 24.1 62.1
Jamnick et al. [85] Active adults M 31 29 25.2 48.6
F 26 27 23.4 39.8
Johnson et al. [86] Recreationally trained runners and cyclists M/F 6/5 22 24.1 46.9
Keiller and Gordon [87] Recreationally trained M/F 9/2 22.4 24.4 51.6
Kirkeberg et al. [88] Recreational-trained men M 12 29 27.5 49.2
Knaier et al. [89] Athletes M 10 27.5 23.1 61.1
F 7 28.4 22.5 54.3
Knaier et al. [90] High cardiorespiratory fitness M 8 27.4 22.8 62.8
F 5 27.6 22.7 55.2
Kramer et al. [91] Soccer players M 15 23.1 23.0 50.5
Mann et al. [92] Runners M 20 30 24.2 60.2
F 12 28 21.7 51.9
Mann et al. [93] Runners M 8 36 24.1 57.9
F 2 32 24.9 49.9
Mauger et al. [94] Well-trained runners M 14 22.7 23.4 64.4
McGawley [95] Recreational runners M/F 5/5 32 NS 59.8
McKay et al. [96] Healthy adults M 12 25 NS 44.5
Midgley et al. [39] Runners M 10 39.3 23.6 53.6
Cyclists M 10 36.0 23.2 57.7
Midgley et al. [97] Middle- and long-distance runners M 16 38.7 23.0 57.1
Midgley et al. [98] Distance runners M 9 38.2 24.6 55.0
Mier et al. [99] College athletes M/F 8/27 20 23.5 55.5
Murias et al. [100] Younger adults M 30 25 24.9 49.4
Older adults M 31 68 25.8 33.0
Murias et al. [101] Older adults F 6 69 27.0 23.9
Younger adults F 8 25 23.8 41.2
Murias et al. [102] Older adults M 8 68 26.0 28.3
Younger adults M 8 23 25.2 48
Nalcakan [103] Healthy adults M 15 21.7 25.0 40.3
Niemela et al. [104] Healthy adults M 16 25–35 23.3 42.5
Niemeyer et al. [105] Physically active M 24 26.2 24.2 49.8
Niemeyer et al. [106] Recreationally trained M 46 25.6 24.0 50.8
Nolan et al. [107] Active adults M/F 6/6 23 22.7 57.5
Poole et al. [37] Healthy adults M 8 27 NS 50.8
Possamai et al. [108] Recreationally trained cyclists M 19 23 25.3 48.0
Riboli et al. [109] Soccer players M 16 22.5 22.4 59.2
Rossiter et al. [38] Healthy adults M 7 26 25.1 51.5
Sabino-Carvalho et al. [110] Runners M 14 22.3 21.2 67.0
F 4 24 20.4 60.1
Scharhag-Rosenberger et al. [111] Healthy adults M/F 20/20 24 23.0 50.0
Scheadler and Devor [112] Experienced runners NS 13 25 22.5 64.9
Sedgeman et al. [113] Recreationally trained M/F 6/7 29 23.9 50.1
(Continued)
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predicted maximal heart rate, 18 used the maximal RER attained in the CPET (RERmax), and 8
used the post-CPET blood lactate concentration.
In terms of processing respiratory VO2 data at volitional exhaustion, the most common
approach was based on time averages. Thirty-eight studies (48%) reported stationary time
averages of 5- to 30-s, whereas 29 (36%) used VO2 data points at fixed intervals of 15- to 30-s,
two studies (3%) used 15-breath averages, two studies (3%) used 10-25-s moving averages, one
(1%) used 10-s epochs, two (3%) used 20-s rolling averages, one (1%) used 30-s rolling means,
and one study (1%) used Douglas bag collections. Four studies (5%) did not detail which VO2
data processing method was applied.
Table 1. (Continued)
Study mean values
Population Sex N Age BMI VO2max
M/F Years kg/m2 mL�kg-1�min-1
Stachenfeld et al. [114] Healthy adults M/F 33/18 30.6 NS 49.2
Straub et al. [115] Trained cyclists M 12 33 24.8 56.5
F 4 38 22.1
Strom et al. [116] Healthy adults M/F 21/29 30.3 24.0 47.3
Taylor et al. [117] Runners and triathlon athletes M 11 28.5 22.6 63.7
F 8 26.3 21.8 52.3
Tucker et al. [118] Nonexercise-trained youth M 17 27 25.6 41.6
Vogiatzis et al. [119] Cyclists M 11 38 22.1 62.0
Weatherwax et al. [120] Sedentary adults M 5 53.6 32.0 32.3
F 11 52.2 29.4 24.8
Weatherwax et al. [15] Sedentary adults (standardized—baseline) M/F 4/16 51.2 29.6 24.3
Sedentary adults (standardized—week 4) M/F 4/16 51.2 29.7 25.0
Sedentary adults (standardized—week 8) M/F 4/16 51.2 29.6 26.3
Sedentary adults (standardized—week 12) M/F 4/16 51.2 29.6 26.3
Sedentary adults (individualized—baseline) M/F 5/14 44.9 27.2 29.5
Sedentary adults (individualized—week 4) M/F 5/14 44.9 27.2 31.1
Sedentary adults (individualized—week 8) M/F 5/14 44.9 27.1 31.3
Sedentary adults (individualized—week 12) M/F 5/14 44.9 27.0 32.8
Weatherwax et al. [121] Sedentary adults (control—baseline) M/F 2/6 45.6 25.5 28.4
Sedentary adults (control—week 12) 25.5 27.7
Sedentary adults (standardized—baseline) M/F 4/16 51.2 29.6 24.3
Sedentary adults (standardized—week 12) 29.6 26.0
Sedentary adults (individualized—baseline) M/F 5/14 44.9 27.1 29.5
Sedentary adults (individualized—week 12) 26.8 32.8
Weatherwax et al. [122] Elite endurance-trained M 18 21.9 19.8 62.8
F 6 20.2 19.4 51.7
Wilhelm et al. [123] Healthy adults M 9 25 25.1 41.0
Williams et al. [124] Healthy adults M 8 27 NS 43.0
M 5 23 NS 48.0
Wingo et al. [125] Healthy adults M 9 25 22.4 61.2
Yeh et al. [126] Healthy adults M/F 14/1 23.3 21.9 48.9
Abbreviations: BMI = body mass index; CRF = cardiorespiratory fitness level; F = female;HIIT = high-intensity interval training;M = male; NS = not stated; VO2max =
maximal oxygen uptake. Note: Whenever possible, authors were contacted to provide unpublished data.
https://doi.org/10.1371/journal.pone.0247057.t001
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VO2 plateau of 2.1 mL�kg
-1�min-1 TR CSI 10-min walking 1st min: "WR until matching the final
stage of CPET; then " slope to 2.5%
and encouraged to running for 2-min
NS
DisCSI
Arad et al. [55] 20-s rolling
mean
VO2 plateau (linear portion of the
VO2-WR relationship); RERmax�
1.10; � 95% APMHR





2×15-s NS CYC Ramp 8-min active 105% WRpeak CPET vs. VP: VO2max
difference � 3.0% and 3.3% and
HRmax� 4 bpm





NS CYC CSI 10-min active one stage > CPET-Stagefinal CPET vs. VP: VO2max




2×15-s NS CYC Ramp 8-min active 2-min at 40–45% WRpeak and then
105% WRpeak
CPET vs. VP: VO2max










NS CYC CSI 10-min active 105% WRpeak VO2max identified as the average
of CPET and VP values
Astorino et al.
[60]
2×15-s NS CYC Ramp � 24h 105%WRpeak reached in the CPET NS
30-s time
average





VO2 plateau (difference between
modelled and actual value >50%
of the regression slope for the
linear portion of the VO2-WR








1st min at 10 km/h (5% slope) and then
" 1 km/h > CPET-Speedpeak
CPET vs. VP: VO2max
difference � 123 ± 18 mL/min
(or 1.7 mL�kg-1�min-1)CSI
(reverse)
Beltz et al. [62] 2×15-s NS TR SPV 20-min passive 2-min at 30% CPET-WRpeak, 1-min at
40–45% CPET-WRpeak and then until
exhaustion at 105% CPET-WRpeak
CPET vs. VP: VO2max
difference � 3%Ramp
Bisi et al. [63] 25-s
moving-
average
VO2 plateau (increase < than 3%
or 2.1 mL�kg-1�min-1 between 2
steps of increment); RERmax�
1.08 or 1.15; HRmax within 10
bpm of APMHR
CYC CSI 6-min active at least 3 min of cycling at 105% of the
WRpeak







NS CYC Ramp Different day See the formula for a proper reporting











VO2 plateau of 150 mL/min;
RERmax� 1.10;� 90% APMHR;





VO2 plateau of 150 mL/min;
RERmax� 1.10; HRmax within 10
bpm of APMHR; RPE �?
CYC CSI Different day 100% WRpeak VO2 plateau of 150 mL/min;
RERmax� 1.10; HRmax within 10





VO2 plateau of 150 mL/min;
RERmax� 1.10;� 90% APMHR;
RPE � 19–20
CYC CSI Different day 100%, 105%, and 110% WRpeak to
attain the highest VO2peak value
VO2 plateau of 150 mL/min;




2×15-s NS CYC CSI 60-min passive 2-min at 50 Watts; then increased
105% WRpeak
CPET vs. VP: VO2max
difference � 3% and HRmax� 4
bpm
Day et al. [35] 30-s time
average





NS TR CSI 10-min passive 0.8 km/h > CPET-Speedpeak NS
Dexheimer
et al. [71]
2×15-s NS TR Pseudo-
ramp
protocol









3-min active WRpeak minus 2 stages NS
(Continued)
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Verification Phase (VP) Protocol Verification Criteria Threshold
Dogra et al.
[73]





NS TR CSI 5-min passive 105% WRpeak NS
Elliott et al.
[75]





VO2 plateau of 2 mL�kg
-1�min-1;
RERmax� 1.10; RPE � 17; HRmax
within 10 bpm of APMHR; Lamax
� 8 mmol
TR CSI 15-min passive " speed over a 30-second period up to






rate of increase in VO2 during the
last min < 50% when compared
to the mid portion of the test
CYC CSI 1-min active 25 Watts > CPET-WRpeak NS
TR CSI 3-min active 1.6 km/h > CPET-Speedpeak or 0.8
km/h if in the non-athlete group
Freeberg et al.
[78]
2×15-s NS TR Incline-
based
protocol




30-s mean NS CYC CSI 5-min passive as described by [38]; however, the
intensity was not stated (i.e. 95 or







VO2 plateau of 2 mL�kg
-1�min-1;
RERmax� 1.10
TR CSI 10-min active one stage > CPET-WRpeak CPET vs. VP: VO2max












VO2 plateau (difference between
modelled and actual value > 50%
of the regression slope for the
linear portion of the VO2-WR
relationship); RERmax� 1.10;
RPE � 17; HRmax within 10 bpm
of APMHR




" speed over a 30-second period up to
a speed stage > CPET-Stagefinal




speed halfway between speedpeak from
the SPVincline vs. predicted verification-
stage speed of the CSI protocol
Speed-
based SPV
speed halfway between speedpeak from
the SPVspeed vs. predicted stage speed





VO2 plateau (linear portion of the
VO2-WR relationship)
CYC Ramp 10-min 110% WRpeak CPET vs. VP: VO2max





VO2 plateau of 2 mL�kg
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NS CYC CSI 3-min active mean WRpeak minus 2 stages CPET vs. VP: VO2max






NS CYC CSI 3-min active (50%
WRpeak)






VO2 plateau (increase < than 50
or 100 mL/min) and HR plateau
(increase < than 2 or 4 bpm) over





6-min passive 10 (female) and 9 (male) km/h and the
" 1% > CPET-Slope
CPET vs. VP: HRmax








3-min active CPET-Speedend minus 2 stages, where













RERmax� 1.10;� 95% APMHR;
RPE � 19; Lamax� 8 mmol
CYC CSI 10-min active 2 min at 50% WRpeak, 1 min at 70%
WRpeak, and then 1
stage > CPET-WRpeak






RERmax�1.05, 1.10 and 1.15; 90,
95 and 100% APMHR; RPE � 19
and = 20; Lamax� 8 and 10 mmol
CYC CSI 10-min active 2 min at 50% WRpeak, 1 min at 70%
WRpeak, and then 1
stage > CPET-WRpeak










15-s NS TR CSI 8-10-min 0.5 km/h > CPET-Speedpeak NS
Mann et al.
[93]





VO2 plateau (increase < than 1.8
mL�kg-1�min-1 between 2 steps of
increment); RERmax� 1.10;
HRmax within 10 bpm of
APMHR; RPE � 17; Lamax� 8
mmol
TR CSI 10-min active one stage > the last completed stage of
the CPET
CPET vs. VP: VO2max





VO2 plateau (increase < than 3%
or 2 mL�kg-1�min-1 between 2
steps of increment); RERmax�
1.15; HRmax within 10 bpm of
APMHR; Lamax� 8 mmol











VO2 plateau (difference between
modelled and actual value > 50%
of the regression slope for the
linear portion of the VO2-WR
relationship)
CYC CSI 10-min passive 2 min at 50% WRpeak, 1 min at 70%
WRpeak, and then 1
stage > CPET-WRpeak, 2 min at 50%
WRpeak, 1 min at 70% WRpeak, and
then 1 stage > CPET-WRpeak
CPET vs. VP: modelled and
verification VO2
difference > 50% of the
regression slope of the individual







absolute plateau in VO2; RERmax
� 1.10; HRmax within 10 bpm of
APMHR
TR CSI 10-min active 0.5 km/h > CPET-Speedpeak CPET vs. VP: VO2max







NS TR CSI 1-min
stages
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Verification Phase (VP) Protocol Verification Criteria Threshold
Mier et al. [99] 30-s VO2 plateau (2 mL�kg
-1�min-1
and � SD of the expected
increase); RERmax� 1.05, 1.10
and 1.15; � 85% APMHR and
HRmax within 10 bpm of APMHR
TR CSI 10-min active
(walking at slow
pace)
intensity gradually increased over
2-min until match CPET-WRpeak; after
1 min, the slope was increased 2.5% to
running for 2-min
CPET vs. VP: VO2max






NS CYC Ramp 5-min active 85% WRpeak CPET vs. VP: VO2max
difference � 2.0 mL�kg-1�min-1105% WRpeak
Murias et al.
[101]
20-s NS CYC Ramp 5-min active 85%WRpeak reached in the CPET NS
Murias et al.
[102]
20-s NS CYC Ramp 5-min active 85%WRpeak reached in the CPET NS
Nalcakan
[103]
30-s VO2 plateau; RERmax� 1.20; �
90% APMHR
CYC CSI Different day 100% WRpeak NS
Niemela et al.
[104]
every min VO2 plateau (�60 mL/min for
men and�50 mL/min for
women); adequacy of a subjective
criterion for establishing the end
point; RERmax� 1.15; HRmax
within 10 bpm of APMHR
CYC CSI I Different day 1 or 2 sub peak WRs, then 100% of the
highest VO2max reached from two
CPET
�5% difference between the





< half of expected increase in
VO2 (i.e. <4.5 mL�kg
-1�min-1)






VO2 plateau (difference between
modelled and actual value > 50%
of the regression slope for the
linear portion of the VO2-WR
relationship)




2×15-s NS TR CSI 20-min passive 105% WRpeak CPET vs. VP: VO2max
difference � 3%115% WRpeak




20 s VO2 plateau of regarding the mL/
min; RERmax� 1.10, 1.15; HRmax
within 10 bpm of APMHR; Lamax
� 8 mmol





plateau in VO2 and HR (i.e.� 50
mL/min or� 2 bpm) over the
final two consecutive 30 s
sampling periods; HRmax within
10 bpm of APMHR
CYC CSI 15-min passive 5-min warm-up at the first stage of the
CPET; 3-min of passive recovery;
2-min at 20 Watts; then increased
100% WRpeak






VO2 plateau of 2.1 mL�kg
-1�min-1 TR CSI with 1
min stages
5-min passive if the CPET did not show a VO2
plateau, a verification bout was
performed as described by [38];
however, the intensity was not stated










VO2 plateau (linear least squares
fitting technique)
CYC Ramp 5-min active 105%WRpeak reached in the CPET NS










(walking at 5 km/
h)
2-min at 60% WRpeak and then " 0.5
km/h > CPET-Speedpeak







VO2 plateau (increase < than
one-third of the oxygen
requirement of a stage change ~
150 mL/min); RERmax� 1.10; ±
10 bpm APMHR; Lamax > 8
mmol
TR DisCSI 10-min passive
(VerifDay1)
1 min at 60% CPET-Speedpeak and
then continued at 110% (or 115% if
necessary, a second VF bout in
VerifDay1) CPET-Speedpeak
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Regarding the period between the CPET and verification phase procedure, 34 studies (43%)
used a short-term active recovery (e.g. pedaling at light-intensity, walking at a slow pace, or
stretching) of 1, 3, 5, 6, 8, 10, or 5–10 min, while 26 studies (33%) employed passive recovery













Verification Phase (VP) Protocol Verification Criteria Threshold
Scheadler and
Devor [112]
30-s NS TR CSI Different day 8% slope/ individualized speed for a
WR greater than CPET (mean
estimated 10.2% WRpeak)
CPET vs. VP: VO2max





VO2 plateau of 2.1 mL�kg
-1�min-1
during the last two 15-s average
samples






VO2 plateau of 150 mL/min;
RERmax� 1.10, 1.15; � 85%
APMHR; Lamax� 8 mmol
CYC CSI Different day 115% WRpeak reached in the CPET or
125% if the plateau has not been
attained












NS TR CSI 3-min active
(walking pace of
67 m/min)






NS TR CSI 15-min active or
passive
1st min at 10 km/h (5% slope) and then




2×15-s NS CYC CSI 5–10 min active 100%WRpeak NS
Vogiatzis et al.
[119]
NS NS CYC CSI 20-min passive 110% WRpeak NS
Weatherwax
et al. [120]
2×15-s NS TR Pseudo-
ramp
protocol




2×15-s NS TR Pseudo-
ramp
protocol




2×15-s NS TR Pseudo-
ramp
protocol




2×15-s NS TR DisCSI 20-min passive 3 min at 4.82 km/h and then " 0.64
km/h > CPET-Speedpeak (males)
CPET vs. VP: VO2max
difference � 3%
3 min at 4.82 km/h and then " 0.48






NS CYC CSI 5-min passive 105%WRpeak NS
Williams et al.
[124]
20-s NS CYC Ramp 5-min active 105%WRpeak NS
Wingo et al.
[125]
2×30-s VO2 plateau of 135 mL/min; HR
within 5 bpm of that on the
control test was obtained
CYC CSI
control
20-min passive 100% WRpeak (if <1-min was
completed during the last stage of the
CPET) or 25 Watts > CPET-WRpeak
(if�1-min was completed during the
last stage of the CPET)





Yeh et al. [126] NS NS TR CSI 10-min passive 1 km/h > CPET-Speedpeak or 5% slope
every minute until exhaustion
NS
Abbreviations: APMHR = age-predicted maximal heart rate; CPET = cardiopulmonary exercise test; CSI = continuous step-incremented; CV = coefficient of variation;
CYC = cycling; DisCSI = discontinuous step-incremented; HR = heart rate;HRmax = maximal heart rate; Lamax = maximal blood lactate concentration; NS = not stated;
RERmax = maximal respiratory exchange ratio; RPE = rating of perceived exertion; SD = standard deviation; SPV = self-paced maximal oxygen uptake; TR = treadmill;
VO2 = oxygen uptake; VO2max = maximal oxygen uptake; VP = verification phase;WR = work rate;WRpeak = peak work rate. Note: whenever possible, authors were
contacted to provide unpublished data.
https://doi.org/10.1371/journal.pone.0247057.t002
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and active recovery and another (1%) used a self-paced approach where participants were per-
mitted to choose their own WR. Three studies (4%) employed short-term recovery (e.g. 8–10
min) without stating whether it was active or passive. Fifteen studies (19%) carried out the ver-
ification phase on a different day to the CPET.
Sixty studies (75%) used square-wave verification phase protocols, while 20 studies (25%)
used multistage verification protocols characterized by an initial warm-up stage. Overall, 53
studies (66%) adopted “supra WRpeak” verification phases based upon the WRpeak achieved
during the CPET (e.g. one treadmill or cycle ergometer WR stage higher than that completed
in the CPET, or 105–130% of the WRpeak achieved in the previous CPET). Seven studies (9%)
used only 100% of WRpeak, while two other studies (3%) used both WRpeak and supra WRpeak
verification phases. Three studies (4%) examined both sub and supra WRpeak within the same
study and one study (1%) used a predicted WR based on the following formula to elicit the
participant’s limit of tolerance within 180 s: power output = (finite work capacity� 180 s) +
critical power. Fourteen studies (18%) used only sub WRpeak verification phases ranging from
85%-95% WRpeak (typically two stages below the WRpeak achieved during the CPET) (see
Table 2).
Forty-two studies (53%) employed cut-off points to analyze differences between the highest
VO2 values obtained during the CPET and verification phase to confirm that VO2max was
likely attained. Criteria for VO2max verification were frequently based on the intra-subject
coefficient of variation acquired from the researchers’ laboratories or from published litera-
ture, including a VO2 difference� 2%,� 3%,� 5.0–5.5%,� 1.5–2.2 mL�kg
-1�min-1,� 50–150
mL/min, or alternative methods.
Quantitative data synthesis: Differences between the highest VO2 attained
in the CPET and verification phase
Table 3 shows comparisons between the highest VO2 values elicited in the CPET and verifica-
tion phase for each study. Fig 2 displays the forest plots of effect sizes and 95% CIs for the high-
est VO2 values (54 studies) based on the random effects meta-analysis results. Notably, the
mean highest VO2 values were similar between the CPET and verification phase (mean differ-
ence = 0.03 [95% CI = -0.01 to 0.06] L/min, P = 0.15). Pooled data for VO2max following the
CPET and verification phase showed no significant heterogeneity among the studies overall
(see Fig 2). Except for one of the included studies judged to have a high risk of bias [68], the
meta-analyzed studies were judged to have a low-risk of bias as shown by the funnel plot
(Fig 3).
Results of subgroup analyses according to the characteristics of the verification phase proto-
col are summarized in Fig 4. There were no significant differences between the CPET and veri-
fication phase for the highest VO2 values attained after stratifying studies for verification-
phase intensity (mean difference = 0.03 [95% CI = -0.01 to 0.07] L/min, P = 0.11), type of
recovery utilized (mean difference = 0.02 [95%CI = -0.02 to 0.07] L/min, P = 0.36), VO2max
verification criterion adoption (mean difference = 0.02 [95% CI = -0.02 to 0.06] L/min,
P = 0.29), verification procedure with regards to whether or not it was performed on the same
day as the CPET (mean difference = 0.03 [95%CI -0.01 to 0.06] L/min, P = 0.21), or verifica-
tion-phase duration (i.e. no longer than 80 s, from 81 to 120 s and longer than 120 s) (mean
difference = 0.03 [95%CI -0.03 to 0.09] L/min, P = 0.35).
Subgroup analyses regarding sex, cardiorespiratory fitness level, exercise modality, and
CPET protocol are summarized in Table 4. The median time to exhaustion was 665 s (IQR,
600 s) for the CPET and 148 s (IQR, 110 s) for the verification phase. Considering all sub-
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Table 3. Overall comparisons in the meta-analyzed studies for the highest VO2 values attained in the cardiopulmonary exercise test (CPET) and verification phase
(VP) (k = 54).
Study Specific Experimental Condition CPET VP % Weight Mean Difference
Mean [L/min] SD [L/min] Total Mean [L/min] SD [L/min] Total IV, Random, 95%CI [L/min]
Alexander and Mier [54] CPET protocol (CSI) 3.79 0.39 11 3.80 0.49 11 1.00% -0.01 [-0.38, 0.36]
CPET protocol (DisCSI) 3.94 0.40 11 3.84 0.45 11 1.00% 0.10 [-0.25, 0.46]
Arad et al. [55] N/A 2.18 0.61 35 2.26 0.65 35 1.40% -0.08 [-0.38, 0.22]
Astorino and DeRevere [56] CPET-VP recovery (8 min) VP intensity (105% WRpeak) 3.35 1.01 30 3.32 1.00 30 0.50% 0.03 [-0.48, 0.54]
CPET-VP recovery (10 min) VP intensity (110% WRpeak) 2.82 0.62 79 2.78 0.59 79 3.70% 0.04 [-0.15, 0.23]
Astorino and White [57] N/A 3.00 0.45 30 3.00 0.45 30 2.50% 0.00 [-0.23, 0.23]
Astorino et al. [53] Experimental groups (low CRF) 2.35 0.37 10 2.36 0.33 10 1.40% -0.01 [-0.32, 0.30]
Experimental groups (moderate CRF) 3.32 0.58 10 3.28 0.60 10 0.50% 0.04 [-0.48, 0.56]
Experimental groups (high CRF) 4.38 0.70 10 4.29 0.74 10 0.30% 0.09 [-0.54, 0.72]
Astorino et al. [58] Training effect (HIIT-Baseline) 2.51 0.62 14 2.50 0.61 14 0.60% 0.01 [-0.45, 0.47]
Training effect (HIIT—Week 3) 2.66 0.67 14 2.60 0.64 14 0.60% 0.06 [-0.43, 0.55]
Training effect (Control—Baseline) 2.94 0.72 14 2.87 0.71 14 0.50% 0.07 [-0.46, 0.60]
Training effect (Control—Week 3) 2.97 0.74 14 2.84 0.69 14 0.50% 0.13 [-0.40, 0.66]
Astorino et al. [59] N/A 2.55 0.62 14 2.57 0.61 14 0.60% -0.02 [-0.47, 0.43]
Astorino et al. [60] CPET-VP recovery (at least 24h) 2.37 0.69 15 2.31 0.75 15 0.50% 0.06 [-0.45, 0.58]
CPET-VP recovery (60 to 90 min) 2.72 0.65 9 2.73 0.72 9 0.30% -0.01 [-0.64, 0.62]
Beltrami et al. [61] Experimental groups (control group) 4.50 0.58 13 4.43 0.46 13 0.80% 0.07 [-0.33, 0.47]
Experimental groups (reverse group) 4.52 0.36 13 4.54 0.33 13 1.90% -0.02 [-0.28, 0.24]
Beltz et al. [62] CPET protocol (SPV) 3.84 0.28 16 3.74 0.50 16 1.70% 0.10 [-0.18, 0.38]
CPET protocol (Ramp) 3.86 0.28 16 3.77 0.50 16 1.70% 0.09 [-0.19, 0.37]
Bisi et al. [63] N/A 2.41 0.13 11 2.56 0.36 11 2.60% -0.15 [-0.38, 0.08]
Chidnok et al. [64] N/A 4.32 0.61 7 4.32 0.69 7 0.30% 0.00 [-0.68, 0.68]
Colakoglu et al. [68] N/A 4.11 0.69 9 4.56 0.60 9 0.40% -0.45 [-1.05, 0.15]
Dalleck et al. [69] N/A 2.33 0.76 18 2.31 0.76 18 0.50% 0.02 [-0.48, 0.52]
Day et al. [35] N/A 3.64 0.70 38 3.64 0.70 38 1.30% 0.00 [-0.31, 0.31]
Dicks et al. [72] N/A 3.84 0.65 28 3.72 0.60 28 1.20% 0.12 [-0.21, 0.45]
Ducrocq et al. [74] N/A 3.73 0.47 13 3.76 0.45 13 1.10% -0.03 [-0.39, 0.32]
Elliott et al. [75] N/A 4.26 0.61 8 4.26 0.70 8 0.30% 0.00 [-0.64, 0.64]
Foster et al. [77] VP exercise modality (TR) 4.09 0.97 20 4.03 1.16 20 0.30% 0.06 [-0.60, 0.72]
VP exercise modality (CYC) 3.95 0.75 20 4.06 0.75 20 0.60% -0.11 [-0.57, 0.35]
Freeberg et al. [78] N/A 3.49 0.85 30 3.49 0.85 30 0.70% 0.00 [-0.43, 0.43]
Goodall et al. [79] N/A 4.11 0.56 9 3.82 0.71 9 0.40% 0.29 [-0.30, 0.88]
Hogg et al. [82] N/A 4.87 0.43 14 4.82 0.48 14 1.20% 0.05 [-0.29, 0.39]
Iannetta et al. [25] WRpeak 5 W/min 1
st VP at 110% WRpeak (25 W/min) 3.35 0.68 11 3.30 0.65 11 0.4% 0.05 [-0.51, 0.61]
2nd VP at 110% WRpeak (5 W/min) 3.35 0.68 11 3.45 0.68 11 0.4% -0.10 [-0.67, 0.47]
WRpeak 10 W/min 1
st VP at 110% WRpeak (25 W/min) 3.44 0.67 11 3.33 0.62 11 0.4% 0.11 [-0.43, 0.65]
2nd VP at 110% WRpeak (10 W/min) 3.44 0.67 11 3.47 0.7 11 0.4% -0.03 [-0.60, 0.54]
WRpeak 15 W/min 1
st VP at 110% WRpeak (25 W/min) 3.44 0.69 11 3.3 0.68 11 0.4% 0.14 [-0.43, 0.71]
2nd VP at 110% WRpeak (15 W/min) 3.44 0.69 11 3.39 0.64 11 0.4% 0.05 [-0.51, 0.61]
WRpeak 25 W/min 1
st VP at 110% WRpeak (25 W/min) 3.44 0.74 11 3.28 0.67 11 0.4% 0.16 [-0.43, 0.75]
2nd VP at 110% WRpeak (25 W/min) 3.44 0.74 11 3.29 0.66 11 0.4% 0.15 [-0.44, 0.74]
WRpeak 30 W/min 1
st VP at 110% WRpeak (25 W/min) 3.44 0.72 11 3.31 0.67 11 0.4% 0.13 [-0.45, 0.71]
2nd VP at 110% WRpeak (30 W/min) 3.44 0.72 11 3.28 0.65 11 0.4% 0.16 [-0.41, 0.73]
Jamnick et al. [84] CPET protocol (CSI1: 1-min stage length) 4.72 0.41 17 4.65 0.45 17 1.60% 0.07 [-0.22, 0.36]
CPET protocol (CSI3: 3-min stage length) 4.62 0.42 17 4.56 0.46 17 1.50% 0.06 [-0.23, 0.36]
CPET protocol (CSI5: 5-min stage length) 4.55 0.46 17 4.55 0.47 17 1.30% 0.00 [-0.31, 0.31]
CPET protocol (CSI7: 7-min stage length) 4.44 0.42 17 4.37 0.46 17 1.50% 0.07 [-0.22, 0.36]
CPET protocol (CSI10: 10-min stage length) 4.35 0.43 17 4.23 0.51 17 1.30% 0.12 [-0.20, 0.43]
Jamnick et al. [85] N/A 3.24 0.57 57 3.25 0.57 57 3.00% -0.02 [-0.23, 0.19]
Johnson et al. [86] N/A 3.31 0.76 11 3.34 0.82 11 0.30% -0.03 [-0.69, 0.63]
Keiller and Gordon [87] N/A 3.65 0.71 11 3.50 0.58 11 0.50% 0.15 [-0.39, 0.69]
Kirkeberg et al. [88] CPET protocol (short-term CSI) 4.43 0.48 12 4.41 0.54 12 0.80% 0.03 [-0.38, 0.43]
CPET protocol (middle-term CSI) 4.40 0.46 12 4.27 0.40 12 1.00% 0.13 [-0.21, 0.47]
CPET protocol (large-term CSI) 4.42 0.42 12 4.36 0.45 12 1.00% 0.06 [-0.29, 0.41]
Kramer et al. [91] N/A 3.45 0.29 15 3.42 0.25 15 3.50% 0.03 [-0.16, 0.22]
(Continued)
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Table 3. (Continued)
Study Specific Experimental Condition CPET VP % Weight Mean Difference
Mean [L/min] SD [L/min] Total Mean [L/min] SD [L/min] Total IV, Random, 95%CI [L/min]
Mann et al. [93] N/A 4.11 0.78 10 4.13 0.85 10 0.30% -0.02 [-0.74, 0.70]
Mann et al. [92] N/A 3.80 0.87 32 3.78 0.92 32 0.70% 0.03 [-0.41, 0.46]
Mauger et al. [94] N/A 4.66 0.55 14 4.65 0.59 14 0.70% 0.01 [-0.42, 0.43]
McGawley [95] N/A 4.08 0.47 10 4.01 0.46 10 0.80% 0.08 [-0.33, 0.48]
Midgley et al. [39] VP exercise modality (CYC) 3.86 0.39 10 3.92 0.47 10 0.90% -0.05 [-0.43, 0.33]
VP exercise modality (TR) 4.05 0.47 10 3.96 0.38 10 0.90% 0.10 [-0.28, 0.47]
Midgley et al. [98] CPET protocol (CSI 1-min stages) 4.09 0.54 9 4.07 0.53 9 0.50% 0.03 [-0.47, 0.52]
CPET protocol (DisCSI 2-min stages) 4.10 0.52 9 4.08 0.52 9 0.60% 0.02 [-0.46, 0.50]
CPET protocol (DisCSI 3-min stages) 3.98 0.49 9 4.07 0.53 9 0.60% -0.09 [-0.56, 0.38]
Midgley et al. [97] N/A 4.03 0.42 16 4.01 0.44 16 1.50% 0.01 [-0.28, 0.31]
Mier et al. [99] N/A 3.64 0.38 10 3.77 0.38 10 1.20% -0.13 [-0.46, 0.20]
Murias et al. [100] VP intensity (younger: 85% WRpeak) 3.73 0.51 8 3.76 0.48 8 0.60% -0.03 [-0.52, 0.45]
VP intensity (younger: 105% WRpeak) 3.90 0.65 22 3.89 0.64 22 0.90% 0.02 [-0.36, 0.40]
VP intensity (older: 85% WRpeak) 2.18 0.55 8 2.18 0.55 8 0.50% 0.00 [-0.54, 0.54]
VP intensity (older: 105% WRpeak) 2.52 0.54 23 2.57 0.51 23 1.40% -0.05 [-0.36, 0.25]
Niemela et al. [104] N/A 3.05 0.55 16 3.05 0.49 16 1.00% 0.00 [-0.36, 0.35]
Niemeyer et al. [105] N/A 4.06 0.43 24 4.06 0.46 24 2.10% 0.00 [-0.25, 0.24]
Niemeyer et al. [106] N/A 4.01 0.47 46 3.95 0.51 46 3.30% 0.06 [-0.14, 0.26]
Nolan et al. [107] CPET-VP recovery (20 min) VP intensity (105% WRpeak) 3.64 0.61 12 3.66 0.58 12 0.60% -0.02 [-0.50, 0.46]
CPET-VP recovery (20 min) VP intensity (115% WRpeak) 3.68 0.59 12 3.64 0.61 12 0.60% 0.04 [-0.44, 0.52]
CPET-VP recovery (60 min) VP intensity (105% WRpeak) 3.60 0.58 12 3.60 0.58 12 0.60% 0.00 [-0.46, 0.46]
CPET-VP recovery (60 min) VP intensity (115% WRpeak) 3.65 0.54 12 3.58 0.60 12 0.60% 0.07 [-0.38, 0.52]
Poole et al. [37] N/A 4.03 0.28 7 3.95 0.29 7 1.50% 0.08 [-0.22, 0.38]
Possamai et al. [108] N/A 3.83 0.41 19 3.72 0.42 19 1.90% 0.11 [-0.15, 0.37]
Rossiter et al. [38] VP intensity (105%WRpeak) 4.15 0.50 5 4.09 0.45 5 0.40% 0.06 [-0.53, 0.65]
VP intensity (95%WRpeak) 4.11 0.48 5 4.12 0.53 5 0.30% -0.01 [-0.64, 0.61]
Sabino-Carvalho et al. [110] Pre-CPET intervention (IPC) 4.24 0.46 16 4.23 0.40 16 1.50% 0.01 [-0.29, 0.31]
Pre-CPET intervention (Sham) 4.23 0.48 16 4.23 0.43 16 1.30% 0.01 [-0.31, 0.32]
Pre-CPET intervention (Control) 4.23 0.38 16 4.15 0.32 16 2.20% 0.08 [-0.17, 0.32]
Scharhag-Rosenberger et al. [111] CPET-VP recovery (same day after 10 min) 3.82 0.99 34 3.72 0.99 34 0.60% 0.10 [-0.37, 0.57]
CPET-VP recovery (different day) 3.82 0.99 34 3.75 1.00 34 0.60% 0.07 [-0.40, 0.54]
Sedgeman et al. [113] VP intensity (WRpeak minus 2-stages) 3.69 0.41 13 3.70 0.49 13 1.10% -0.01 [-0.36, 0.34]
VP intensity (105%WRpeak) 3.71 0.51 13 3.64 0.50 13 0.90% 0.07 [-0.31, 0.46]
Straub et al. [115] N/A 3.86 0.73 16 3.84 0.68 16 0.60% 0.02 [-0.47, 0.51]
Taylor et al. [117] N/A 4.03 0.53 19 3.83 0.52 19 1.20% 0.21 [-0.13, 0.54]
Weatherwax et al. [120] N/A 2.29 0.73 16 2.29 0.73 16 0.50% 0.00 [-0.50, 0.51]
Weatherwax et al. [15] Training effect (standardized—baseline) 2.03 0.62 20 2.03 0.60 20 0.90% 0.00 [-0.38, 0.38]
Training effect (standardized—week 12) 2.17 0.62 20 2.18 0.63 20 0.90% -0.01 [-0.40, 0.38]
Training effect (individualized—baseline) 2.37 0.79 19 2.37 0.77 19 0.50% 0.00 [-0.50, 0.50]
Training effect (individualized—week 12) 2.63 0.89 19 2.65 0.89 19 0.40% -0.02 [-0.59, 0.55]
Weatherwax et al. [121] Training effect (control—baseline) 2.18 0.74 8 2.16 0.73 8 0.30% 0.02 [-0.70, 0.74]
Training effect (control—week 12) 2.11 0.73 8 2.10 0.69 8 0.30% 0.01 [-0.69, 0.71]
Training effect (standardized—baseline) 2.03 0.62 20 2.03 0.60 20 0.90% 0.00 [-0.38, 0.38]
Training effect (standardized—week 12) 2.17 0.62 20 2.18 0.63 20 0.90% -0.01 [-0.40, 0.38]
Training effect (individualized—baseline) 2.37 0.79 19 2.37 0.77 19 0.50% 0.00 [-0.50, 0.50]
Training effect (individualized—week 12) 2.63 0.89 19 2.65 0.89 19 0.40% -0.02 [-0.59, 0.55]
Weatherwax et al. [122] Experimental groups (males) 3.98 0.36 18 3.94 0.32 18 2.60% 0.04 [-0.19, 0.26]
Experimental groups (females) 2.68 0.13 6 2.67 0.10 6 8.00% 0.01 [-0.12, 0.14]
Abbreviations: CI = confidence interval; CPET = cardiopulmonary exercise test; CRF = cardiorespiratory fitness level; CSI = continuous step-incremented; CYC =
cycling; DisCSI = discontinuous step-incremented; HIIT = high-intensity interval training; IPC = ischemic preconditioning; N/A = not applicable; TR = treadmill; SD =
standard deviation; SPV = self-paced maximal oxygen uptake; VO2 = oxygen uptake; VP = verification phase;WRpeak = peak work rate; W/min = incremental phase
based on watts perminute. Note: whenever possible, authors were contacted to provide unpublished data. %Weight = weight attributed to each study due to its statistical
power.
https://doi.org/10.1371/journal.pone.0247057.t003
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Fig 2. Forest plot of all studies included in the meta-analysis (k = 54) for the highest VO2 responses attained in the
cardiopulmonary exercise test and verification phase using random effects analyses. Data are reported as mean
differences (MD) adjusted for control data (95% CIs).
https://doi.org/10.1371/journal.pone.0247057.g002
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analyses presented in Table 4, there were no significant differences between the CPET and ver-
ification phase for VO2max (P = 0.18 to P = 0.71).
Discussion
A growing number of studies have included the verification phase procedure to increase confi-
dence that the highest possible VO2 has been elicited by apparently healthy adults during a
CPET. To the best of our knowledge this is the first systematic review and meta-analysis of
these studies, and evidences that 90% of which have been published since 2009. The major
findings were: (a) in general, the verification phase protocols elicited similar highest VO2 val-
ues to those obtained in the preceding CPET protocols; and (b) concordance between the
highest VO2 values in the CPETs and verification phases were not affected by sex, cardiorespi-
ratory fitness level, exercise modality, CPET protocol, or verification phase protocol.
The present systematic review and meta-analysis shows that the highest mean VO2 values
elicited by verification phase bouts were similar to those elicited in continuous ramp or
pseudo-ramp CPET protocols in the majority of studies. In fact, the mean absolute difference
of 0.03 L/min for the 54 studies included in the meta-analysis represents a relative difference
of only 0.85% between the highest VO2 values attained in the CPET and verification phase.
This is within the most commonly adopted measures of test variability of 2–3% [57, 97]. The
Fig 3. Funnel plot assessment of publication bias for the studies investigating the highest VO2 responses attained in the cardiopulmonary exercise test
and verification phase.
https://doi.org/10.1371/journal.pone.0247057.g003
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present findings also provide evidence that the similarity between the highest VO2 values
attained during the CPETs and verification phases are not affected by sex, cardiorespiratory
fitness, exercise modality, CPET protocol design, or how the verification phase was performed
(see Table 4 and Fig 4). This contrasts with traditional VO2max criteria, which are test-protocol
Fig 4. Mean differences (95% CIs) between the highest VO2 responses in the cardiopulmonary exercise test (CPET) and verification phase according to
the verification-phase characteristics for intensity (i.e. sub WRpeak vs. supra WRpeak), recovery (i.e. active vs. passive), adoption of criterion threshold (i.e.
yes vs. no), timing (performed on the same day vs. a different day to the CPET), and duration (i.e. no longer than 80 s, from 81 to 120 s and longer than
120 s).
https://doi.org/10.1371/journal.pone.0247057.g004
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dependent and vary according to the individual’s physical characteristics [28, 29]. Day et al.
[35], for example, observed that participants with lower cardiorespiratory fitness had a lower
tendency to exhibit a deceleration in the VO2 response at the end of a CPET compared to
those with higher cardiorespiratory fitness and, therefore, are less likely to exhibit a VO2
plateau.
Six of the 54 meta-analyzed studies reported significant mean differences between the high-
est VO2 values observed in the CPET and verification phase [25, 55, 56, 68, 87, 95]. Astorino
and DeRevere [56], for example, observed significantly higher mean VO2max values by 0.03
and 0.04 L/min during the CPET than in the verification phase for two samples of participants
heterogeneous for cardiorespiratory fitness. However, sub-group analyses revealed that while
maximal VO2 in the CPET was higher than that attained in the verification phase for partici-
pants with moderate and high cardiorespiratory fitness, the opposite was true for those with
lower cardiorespiratory fitness. Similar findings have been reported by Arad et al. [55], indicat-
ing that cardiorespiratory fitness level may be a key moderator of the differences between the
highest VO2 values attained in the CPET and verification phase. A plausible explanation is that
individuals with low cardiorespiratory fitness are more susceptible to stopping early during
the CPET due to fatigue-associated symptoms [29], which would tend to result in lower VO2
values. In the present meta-analyses, the mean VO2max in the verification phase was 8% higher
than in the CPET in the low cardiorespiratory fitness group, but 12% and 10% higher in the
CPET than in the verification phase in the moderate and high cardiorespiratory fitness groups,
respectively (see Table 4). The lack of statistical significance, however, highlights the uncer-
tainty regarding the effects of cardiorespiratory fitness on the differences between the highest
VO2 values in the CPET and verification phase.
Regarding verification-phase duration, Keiller and Gordon [87] observed significantly
higher VO2 values during the incremental treadmill CPETs versus the verification phase with
a mean duration of approximately 2 min. This is consistent with the findings of McGawley
Table 4. Subgroup analyses for the cardiopulmonary exercise test (CPET) and verification phase (VP).
Time to exhaustion (s) VO2max (L/min)
N CPET Mean ± SD VP Mean ± SD N CPET Mean ± SD VP Mean ± SD Effect Size (95% CI) P-value
Sex
Male 146 734 ± 90 244 ± 43 630 3.95 ± 0.48 3.93 ± 0.50 0.02 (-0.02 to 0.08) 0.25
Female 23 659 ± 119 152 ± 46 68 2.63 ± 0.39 2.58 ± 0.40 0.05 (-0.08 to 0.12) 0.71
Both 677 765 ± 140 146 ± 28 941 3.24 ± 0.67 3.21 ± 0.67 0.03 (-0.04 to 0.08) 0.50
Cardiorespiratory fitness level
Low 170 617 ± 111 150 ± 36 322 2.30 ± 0.65 2.32 ± 0.65 0.02 (-0.07 to 0.11) 0.63
Moderate 362 790 ± 101 200 ± 40 565 3.49 ± 0.61 3.45 ± 0.63 0.04 (-0.02 to 0.11) 0.21
High 346 792 ± 149 161 ± 27 716 3.94 ± 0.55 3.90 ± 0.55 0.04 (-0.02 to 0.08) 0.18
Exercise modality
CYC 477 823 ± 143 155 ± 29 916 3.47 ± 0.59 3.45 ± 0.59 0.02 (-0.03 to 0.07) 0.43
TR 386 688 ± 110 189 ± 34 771 3.59 ± 0.58 3.56 ± 0.58 0.03 (-0.02 to 0.08) 0.22
CPET protocol
DisCSI 92 876 ± 120 156 ± 28 169 3.90 ± 0.52 3.87 ± 0.51 0.03 (-0.05 to 0.11) 0.49
CSI 472 696 ± 105 209 ± 40 924 3.71 ± 0.56 3.69 ± 0.58 0.02 (-0.03 to 0.07) 0.38
Ramp 284 848 ± 171 121 ± 23 578 3.16 ± 0.63 3.13 ± 0.62 0.03 (-0.04 to 0.09) 0.44
Group weighted mean differences in maximal oxygen uptake (VO2max) according to sex, cardiorespiratory fitness level, exercise testing modality, and CPET protocol.
Abbreviations: CI = confidence interval; CPET = cardiopulmonary exercise test; CSI = continuous step-incremented; CYC = cycling; DisCSI = discontinuous step-
incremented; TR = treadmill; SD = standard deviation; VP = verification phase.
https://doi.org/10.1371/journal.pone.0247057.t004
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[95] for 10 recreational runners who performed five consecutive treadmill CPET trials, plus an
appended verification phase with a mean duration of< 2 min. Iannetta et al. [25] analyzed the
VO2 responses to ramp-incremented cycling CPETs with WR increments of 5, 10, 15, 25,
and 30 W/min, each followed by two verification phases performed at different WRs. The veri-
fication phase bouts performed at 110% of the WRpeak from ramp protocols with ramp rates of
25 and 30 W/min (i.e. short verification phase bouts of ~ 80 s) yielded VO2 values significantly
lower than those attained in the CPETs. In contrast, the highest VO2 values attained during
verification phase bouts based on slower WR increments of 5, 10, and 15 W/min, which
allowed sufficient time for VO2max attainment (i.e. 162, 122 and 103 s, respectively) were not
different to those achieved in the preceding CPETs. Although the aforementioned studies sug-
gest that verification phase duration is a key moderator for the mean differences between the
highest VO2 observed in the CPET and verification phase, our sub-analysis found no differ-
ence for verification-phase durations of� 80 s, ranging from 81 to 120 s, and> 120 s (see Fig
4). Notably, however, only three studies reported short durations of 80 s or less [25, 79, 113]
and the lack of statistical significance may be due to the paucity of data.
In contrast to the aforementioned studies [25, 87, 95], Colakoglu et al. [68] observed signifi-
cantly lower VO2 values in the CPET versus the verification phase in nine cycling and track
and field athletes. According to Midgley et al. [97], if the mean highest VO2 attained in the ver-
ification phase is significantly higher than in the CPET, the investigator should consider that
the CPET protocol was inadequate in eliciting the highest possible VO2 response in all or some
of the participants. In the study by Colakoglu et al. [68], participants performed a prolonged
step-incremented CPET consisting of one 4-min, three 2-min, and then 1-min increments
until volitional exhaustion after 1 h of recovery from a submaximal CPET of at least four
5-min stages. It is feasible that the procedures performed before the maximal CPET may have
led to poor participant motivation, lack of effort and premature fatigue in the following test.
Additionally, the four verification phase bouts at 100%, 105%, 110%, and 115% of the WRpeak
attained in the CPET were performed on four different days to the CPET without any preced-
ing maximal exercise. This also may have positively favored the significantly higher mean VO2
values in the verification phase compared to the CPET and contrasts with the same-day verifi-
cation phase used by Keiller and Gordon [87], McGawley [95], and Iannetta et al. [25].
An aim of the present systematic review was to suggest best practices for the application of
verification phase protocols. The subgroup analyses revealed no systematic bias between the
highest VO2 values observed in the CPET and verification phase according to the verification-
phase intensity (i.e. sub WRpeak vs. supra WRpeak), type of recovery between the CPET and ver-
ification phase (i.e. active vs. passive), whether a VO2max criterion threshold was used for the
CPET (i.e. yes vs. no), whether the verification phase was performed in the same testing session
or on a different day, and the verification-phase duration (see Fig 4). Considering that differ-
ences in the verification phase procedure do not appear to influence its effectiveness, a specific
verification procedure currently cannot be recommended. However, some caution must be
exercised to avoid an inappropriately high verification-phase WR that results in a short test
duration and insufficient time for the highest possible VO2 to be elicited [25], especially in
untrained individuals characterized by slow VO2 kinetics [127]. Midgley et al. [97] stated that
this is a plausible rationale for the early recommendations of Thoden [128], that individuals
who do not reach 3 min in a supra WRpeak verification phase should undertake a subsequent
verification phase at the same WR or one stage lower than verification-phase the last com-
pleted WR stage in the CPET. Poole and Jones [2] suggested that researchers should select a
WR that is sufficiently higher than the WRpeak attained in the CPET, such as ~110% WRpeak,
to give the VO2 signal for the higher WR the opportunity to emerge from the extant noise. If
the subsequent verification phase produces a VO2 plateau signifying VO2max, this signal would
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be lower than expected for the WR based on the previous VO2-WR slope. Conversely, Iannetta
et al. [25] advocated a verification-phase WR lower than the WRpeak attained in the CPET in
order to allow VO2max to be elicited, since WRs above critical power should elicit VO2max if
the time to exhaustion is sufficiently long. Midgley et al. [39] proposed an alternative approach
based on a multistage verification phase protocol that combines WRs below and above WRpeak
to obtain a protocol that incorporates a supra WRpeak intensity with a relatively prolonged ver-
ification-phase duration. This approach has since been adopted in other studies [39, 53, 54, 61,
62, 64, 69, 76, 82, 87, 89, 90, 99, 104, 108, 110, 111, 115, 117, 122]. Notably, the only study to
observe a statistically significant influence of verification phase intensity employed a multi-
stage verification phase protocol incorporating 2 min at 50% of WRpeak, increasing to 70% for
an additional minute, and then 105 or 115% until volitional exhaustion [107]. Based on their
findings, the authors recommended the use of 105% of the WRpeak attained in the CPET rather
than 115% WRpeak. The confounding results and various recommended approaches regarding
the verification phase intensity indicates that more research is required before an evidence-
based recommendation can be made.
Regarding the recovery time between the CPET and verification phase, intervals between
10–20 min have been commonly used, although in total a wide range of intervals from 1–3
min [65, 77, 88, 113] to 90 min [41] have been used. The present meta-analysis found no sig-
nificant effect of recovery time on minimizing the difference between the mean VO2 elicited in
the CPET and verification phase. An alternative method is to perform the verification phase
on a separate day, although the additional visit to the laboratory and the day-to-day variability
in VO2max [129] might considerably reduce the utility and robustness of this approach. Schar-
hag-Rosenberger et al. [111] specifically investigated this issue by comparing a 10-min recov-
ery to a verification phase performed on a separate day. No significant difference was observed
between the two verification protocols, even though the time to exhaustion was significantly
longer when the verification phase was performed on a separate day (2:06 ± 0:22 min vs.
2:42 ± 0:38 min). These findings suggest no advantage in performing the CPET and verifica-
tion phase on separate days.
Inadequate data processing may negatively impact the utility of the verification phase pro-
cedure. Myers et al. [36] suggested small sampling intervals such as 5 and 10 s result in unac-
ceptable variability in VO2 data, whereas large intervals such as 60 s may not be sufficiently
sensitive to accurately track rapid changes in VO2 such as those observed in ramp and pseudo-
ramp CPET protocols. Midgley et al. [130] observed that the reproducibility of VO2max during
continuous step-incremented treadmill CPETs is not affected by the length of the VO2 time-
average interval between the range of 10 to 60 s, however, the actual VO2max values were signif-
icantly different between time averages. The authors suggested that a 30-s stationary time-
average for CPETs provides a good compromise between removing noise while maintaining
the underlying trend in the VO2 data. However, no study to date has addressed the effect of
the VO2 sampling interval on the verification phase.
A final issue to be addressed refers to appropriate criteria to accept that the highest possible
VO2 has been achieved. The most common criterion used in the reviewed studies is that the
highest VO2 observed in the verification phase should not exceed 3% of the highest VO2
obtained in the CPET. This threshold can be justified by the technical error of measurement
and intra-individual biological variation associated with the determination of VO2max [15, 56,
57, 62, 63, 69, 71, 78, 82, 86, 89–91, 95, 107, 108, 113, 116, 120–122]. The more restrictive value
of� 2% [97, 110] and the less restrictive values of� 5–5.5% [104–106, 111] may also be appro-
priate for single or different-day variability. Further research is required before an appropriate
verification-phase threshold can be recommended, which provides a high degree of confidence
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that the difference between the highest VO2 values observed in the CPET and verification
phase are beyond the technical error of measurement and intra-individual biological variation.
Some limitations of the present review need to be acknowledged. First, the meta-analysis
only included 79% of the participants that underwent CPET with verification phase protocols
in the 80 studies included in the systematic review. This issue was due to unsuccessful attempts
to acquire the required unpublished information from some authors. Second, the meta-analy-
sis was based on comparison of the highest VO2 responses in the CPET and verification phase
averaged across study participants. Noakes [131] criticized this approach, stating that the
CPET is performed on individuals and not groups and, therefore, the group average approach
does not identify individuals who may not have attained VO2max. A meta-analysis using indi-
vidual participant data is therefore required. Finally, the present systematic review and meta-
analysis comprised only apparently healthy adults and it is still unclear to what extent the use
of the verification phase procedure is applicable to special or clinical populations. A growing
number of studies have included special or clinical populations such as obese adults [132, 133],
breast and prostate cancer survivors [134], wheelchair athletes [135], individuals with spinal-
cord injuries [136], patients with heart failure [137] or cystic fibrosis [138–140], and pediatric
populations [141–147], including children with spina bifida in an outpatient condition [148],
and adolescents with cystic fibrosis [149].
Conclusions
The present meta-analysis showed that the effect sizes calculated from the highest mean VO2
in apparently healthy adults were similar between CPETs and verification phases performed
on a cycle ergometer or treadmill. Furthermore, mean differences between the highest VO2
values elicited in the CPETs and verification phases were not affected by participant character-
istics, exercise modality, or the CPET and verification protocol design. Our findings indicate
that from a practical perspective, different procedures may be applied to establish similar high-
est mean VO2 responses during the verification phase as compared to the ramp or continuous
step-incremented CPETs. It is worth mentioning, however, that some caution must be exer-
cised concerning the selection of sub or supra WRpeak verification phases, since any exercise
above the critical power must be of sufficient duration to allow the achievement of the highest
possible VO2 response in the verification phase. Our data reinforce the notion that a verifica-
tion phase applied after ramp or continuous step-incremented CPETs may provide additional
and unbiased evidence that the highest possible VO2 has been achieved. On the other hand,
the invalidation of the highest VO2 obtained in CPETs by subsequent verification phases was
less likely on a group basis. The mean differences in highest VO2 responses were typically
within the test-retest variability of the experimental protocols employed. Accordingly, our
findings support the usefulness of the verification phase to confirm the likely attainment of
VO2 on incremental CPET. However, the necessity or mandatory application of the verifica-
tion phase, especially constant supra WRpeak verification bouts, in all CPET situations remains
open to question.
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